Market Place
Sourcing Support
Shanghai Henlius’s Biologics Poherdy Receives Approval In US
13 Nov 2025 //
FDA
Kura Oncology’s Komzifti Receives Approval In US
13 Nov 2025 //
FDA
Sandoz’s Generics Carbidopa Receives Tentative Approval In US
12 Nov 2025 //
FDA
Padagis’s Generics Diazepam Receives Tentative Approval In US
12 Nov 2025 //
FDA
Alembic’s Generics Dexlansoprazole Receives Approval In US
12 Nov 2025 //
FDA
Zydus’s Generics Diroximel Fumarate Receives Approval In US
12 Nov 2025 //
FDA
Gland’s Generics Leucovorin Calcium Receives Approval In US
12 Nov 2025 //
FDA
Laurus’s Generics Sitagliptin Receives Tentative Approval In US
12 Nov 2025 //
FDA
Macleods’s Generics Vortioxetine HBr Recieves Approval In US
10 Nov 2025 //
FDA
Cosette’s Generics Ciprofloxacin HCl Receives Approval in US
10 Nov 2025 //
FDA
Hainan`s Generics Carfilzomib Receives Tentative Approval In US
07 Nov 2025 //
FDA
Qilu’s Generics Abemaciclib Receives Tentative Approval In US
06 Nov 2025 //
FDA
Zydus’s Generics Olaparib Receives Tentative Approval In US
06 Nov 2025 //
FDA
Fresenius’s Generics Sugammadex Receives Tentative Approval In US
06 Nov 2025 //
FDA
Alembic’s Generics Dasatinib Receives Approval In US
06 Nov 2025 //
FDA
Steriscience’s Generics Doxycycline Receives Approval in US
06 Nov 2025 //
FDA
Alembic’s Generics Sumatriptan Succinate Receives Approval in US
06 Nov 2025 //
FDA
Umedica’s Generics Diclofenac Sodium Receives Approval in US
05 Nov 2025 //
FDA
Laurus’s Generics Macitentan Receives Approval in US
05 Nov 2025 //
FDA
Ascent’s Generics Sodium Oxybate Receives Approval in US
05 Nov 2025 //
FDA
MSN Lab’s Generics Vibegron Receives Tentative Approval In US
04 Nov 2025 //
FDA
Alkem’s Generics Bempedoic Acid Receives Tentative Approval In US
04 Nov 2025 //
FDA
Unichem’s Generics Apixaban Receives Tentative Approval In US
04 Nov 2025 //
FDA
MSN’s Generics Irbesartan Receives Approval in US
04 Nov 2025 //
FDA
Rising’s Generics Sulfasalazine Receives Approval in US
04 Nov 2025 //
FDA
MSN’s Generics Mirabegron Receives Approval in US
04 Nov 2025 //
FDA
Amneal’s Generics Phytonadione Receives Approval in US
04 Nov 2025 //
FDA
Shandong’s Generics Isoflurane Receives Approval in US
04 Nov 2025 //
FDA
Rhodes’s Generics Maraviroc Receives Approval in US
04 Nov 2025 //
FDA
Zydus’s Generics Budesonide Receives Tentative Approval In US
03 Nov 2025 //
FDA
Cipla’s Generics Enzalutamide Receives Tentative Approval In US
03 Nov 2025 //
FDA
UCB’s Kygevvi Receives Approval in US
03 Nov 2025 //
FDA
SPH Zhongxi’s Generics Eslicarbazepine Receives Approval in US
03 Nov 2025 //
FDA
MSN’s Generics Vortioxetine HBr Receives Tentative Approval in US
03 Nov 2025 //
FDA
MSN’s Generics Linagliptin, Metformin HCl Receives Approval in US
03 Nov 2025 //
FDA
MSN’s Generics Linagliptin Receives Approval in US
03 Nov 2025 //
FDA
Mylan’s Generics Linagliptin Receives Approval in US
03 Nov 2025 //
FDA
Dr Reddys’s Generics Metformin HCl Receives Approval in US
03 Nov 2025 //
FDA
Aurobindo Pharma’s Generics Linagliptin Receives Approval in US
03 Nov 2025 //
FDA
Dr Reddy’s Generics Linagliptin Receives Approval in US
03 Nov 2025 //
FDA
Apotex’s Generics Axitinib Receives Approval in US
30 Oct 2025 //
FDA
Novugen’s Generics Everolimus Receives Approval in US
30 Oct 2025 //
FDA
Amneal’s Generics Neomycin Receives Approval in US
29 Oct 2025 //
FDA
Micro’s Generics Varenicline Tartrate Receives Approval in US
29 Oct 2025 //
FDA
Sciegen’s Generics Ticagrelor Receives Approval in US
28 Oct 2025 //
FDA
Novast’s Generics Drospirenone, Estradiol Receives Approval in Us
28 Oct 2025 //
FDA
Changzhou Pharm’s Generics Ticagrelor Receives Approval in US
28 Oct 2025 //
FDA
Macleods’s Generics Ticagrelor Receives Approval in US
28 Oct 2025 //
FDA
Taro’s Generics Ticagrelor Receives Approval in US
28 Oct 2025 //
FDA
Alkem’s Generics Ticagrelor Receives Approval in US
28 Oct 2025 //
FDA
Navinta’s Generics Sevelamer Carbonate Receives Approval in US
27 Oct 2025 //
FDA
Ajenat’s Generics Glycopyrrolate Receives Approval in US
27 Oct 2025 //
FDA
Carnegie’s Generics Lomustine Receives Approval in US
27 Oct 2025 //
FDA
Zenara’s Generics Tafamidis Receives Tentative Approval in Us
27 Oct 2025 //
FDA
Eisai’s Leqembi Approved in Canada
24 Oct 2025 //
HEALTH CANADA
Azurity’s Resniben Receives Tentative Approval in US
24 Oct 2025 //
FDA
Bayer Healthcare’s Lynkuet Receives Approval in US
24 Oct 2025 //
FDA
Sterinova’s Rocuronium Bromide Receives Approval in US
24 Oct 2025 //
FDA
Hikma’s Generics Atropine Sulfate Receives Approval in US
24 Oct 2025 //
FDA
MSN’s Generics Rivaroxaban Receives Approval in US
24 Oct 2025 //
FDA
